When the world first heard about a new respiratory virus, it was a surprise to learn that patients were suffering from blood clots, strokes, and heart attacks. Johns Hopkins hematologist Dr. Robert Brodsky talks with Dr. Josh Sharfstein about recent research exploring the role of complement, a part of the immune system, in COVID-related clotting. Brodksy talks about how COVID-19 may be similar to other diseases that involve complement, and the implications of the theory for treatment and diagnosis.
KEYWORDS: spike protein; COVID-19 therapy; endothelium
